SciELO - Scientific Electronic Library Online

 
vol.52 issue3Ensayo de linfoproliferación antígeno específico al virus dengue con células T humanasPresencia de anticuerpos al virus del sarampión en un grupo de pacientes con hemopatías malignas author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Medicina Tropical

Print version ISSN 0375-0760On-line version ISSN 1561-3054

Abstract

RESIK AGUIRRE, Sonia et al. Monitoreo de la infección por citomegalovirus en pacientes con trasplante renal: primera experiencia en Cuba. Rev Cubana Med Trop [online]. 2000, vol.52, n.3, pp.203-210. ISSN 0375-0760.

Kidney transplantation is at present the most efficient therapeutic tool to treat end-stage chronic kidney failure. Graft rejection and infections are the most important barriers to the success of transplantation, whereas cytomegalovirus (CMV) has been the most reported causal agent of morbidity in this type of patients. The evolution of a group of 12 patients who underwent kidney transplantation at the Nephrology Institute was studied during 16 weeks aimed at monitoring the infection caused by CMV. 58.4% of these patients were positive and 28% showed clinical evidences of the disease. Most of the infected patients were observed between the 4th and the 12th week after transplantation. CMV infection was confirmed in 70% of the individuals undergoing a high immunossupression. 50% of the total of patients developed graft rejection episodes some time during the evolution and 83.3% were diagnosed CMV infection.

Keywords : KIDNEY TRANSPLANTATION [adverse effects]; CYTOMEGALOVIRUS INFECTION [drug therapy].

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License